Jones Financial Companies Lllp Acquires 59,006 Shares of Haleon plc (NYSE:HLN)

Jones Financial Companies Lllp lifted its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 57.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 162,187 shares of the company's stock after buying an additional 59,006 shares during the quarter. Jones Financial Companies Lllp's holdings in Haleon were worth $1,547,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Sierra Ocean LLC bought a new position in Haleon in the 4th quarter worth about $26,000. Versant Capital Management Inc boosted its position in shares of Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock valued at $34,000 after acquiring an additional 3,348 shares during the period. Geneos Wealth Management Inc. bought a new position in shares of Haleon in the fourth quarter valued at approximately $35,000. Toronto Dominion Bank grew its stake in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock valued at $38,000 after acquiring an additional 3,470 shares in the last quarter. Finally, Spire Wealth Management bought a new stake in Haleon during the 4th quarter worth approximately $39,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Sanford C. Bernstein cut shares of Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research note on Friday, January 10th. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Six analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Haleon currently has an average rating of "Hold" and a consensus target price of $10.95.

Remove Ads

Haleon Price Performance

NYSE:HLN traded down $0.08 during mid-day trading on Monday, reaching $10.38. The stock had a trading volume of 7,324,520 shares, compared to its average volume of 6,537,607. The stock has a market capitalization of $46.97 billion, a P/E ratio of 30.51, a P/E/G ratio of 2.82 and a beta of 0.25. The firm has a 50 day moving average price of $9.68 and a two-hundred day moving average price of $9.86. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a one year low of $7.89 and a one year high of $10.80.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, analysts expect that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The company also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This is a boost from Haleon's previous -- dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon's dividend payout ratio (DPR) is currently 58.97%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.